Grant: Engage Grants Program
Université du Québec à Montréal
$25,000.00
Development of a rapid detection biosensor for pharmaceutical residues induced-toxicities in algal cells
FY 2014-15
Summary
Pollution from pharmaceuticals in the aquatic environment has been considered as one of the emergingresearch area in environmental chemistry. This has led to the creation of an extensive area of research,including among others their toxicity detection. LBi Innovation Inc. is a biotechnology company whosemission is to develop and market rapid toxicity tests. In this commitment partnership, priority will be given todevelop a new reliable method for the detection of toxicity induced by pharmaceutical residues using sensitivealgal species. This project will be based on the use of different concentrations of pharmaceutical residueswhich permit rapid toxicity detection during test measurements. We will select the most sensitive algal species.In this study, we will use flow cytometry by employing markers 2,7-dichlorodihydrofluorescein diacetate andalso measurements by using Luminotox fluorimeter. In this project, we will consider the following algalspecies Chlamydomonas reinhardtii (wild-type strain cc125 and cc400 without walls) and marine algaDunaliella tertiolecta. Based on our results, we will determine a practical new method to provide highsensitivity toxicity detection induced by the presence of low concentrations of pharmaceutical residues.Therefore, this research will be realized in a close collaboration with researchers of LBi Innovation Inc., andwill permit the development of a new practical and reliable bioassay technology.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
462696-2014
Name nom
Dewez, David
Department département
Chimie
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
400
Area of application group en
Environment
Area of application group fr
Environnement
Area of application en
Environment
Area of application fr
Environnement
Research subject code
5206
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bioremediation
Research subject fr
Biorestauration
Partie
1
Nb partie
1
Application title
Development of a rapid detection biosensor for pharmaceutical residues induced-toxicities in algal cells
Keyword
NSERC
Application summary
Pollution from pharmaceuticals in the aquatic environment has been considered as one of the emergingresearch area in environmental chemistry. This has led to the creation of an extensive area of research,including among others their toxicity detection. LBi Innovation Inc. is a biotechnology company whosemission is to develop and market rapid toxicity tests. In this commitment partnership, priority will be given todevelop a new reliable method for the detection of toxicity induced by pharmaceutical residues using sensitivealgal species. This project will be based on the use of different concentrations of pharmaceutical residueswhich permit rapid toxicity detection during test measurements. We will select the most sensitive algal species.In this study, we will use flow cytometry by employing markers 2,7-dichlorodihydrofluorescein diacetate andalso measurements by using Luminotox fluorimeter. In this project, we will consider the following algalspecies Chlamydomonas reinhardtii (wild-type strain cc125 and cc400 without walls) and marine algaDunaliella tertiolecta. Based on our results, we will determine a practical new method to provide highsensitivity toxicity detection induced by the presence of low concentrations of pharmaceutical residues.Therefore, this research will be realized in a close collaboration with researchers of LBi Innovation Inc., andwill permit the development of a new practical and reliable bioassay technology.